LTRN
Lantern Pharma Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.55
−9.36%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.35
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.57
- EPS estimate
- -$0.38
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +0.9%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.38 | -$0.57 | Miss -50.00% | — |
| May 15, 2026 | -$0.36 | -$0.30 | Beat 16.67% | — |
| Mar 30, 2026 | -$0.46 | -$0.36 | Beat 21.74% | — |
| Nov 12, 2025 | -$0.46 | -$0.39 | Beat 15.22% | — |
| Aug 13, 2025 | -$0.53 | -$0.40 | Beat 24.53% | — |
| May 15, 2025 | -$0.49 | -$0.42 | Beat 14.29% | — |
| Mar 27, 2025 | -$0.51 | -$0.54 | Miss -5.88% | $100.7K |
| Nov 7, 2024 | -$0.56 | -$0.42 | Beat 25.00% | — |
| Aug 8, 2024 | -$0.55 | -$0.46 | Beat 16.36% | — |
| May 9, 2024 | -$0.43 | -$0.51 | Miss -18.60% | — |
| Mar 18, 2024 | -$0.40 | -$0.39 | Beat 2.50% | $261.1K |
| Mar 20, 2023 | -$0.47 | -$0.31 | Beat 34.04% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026